ProShares UltraShort Nasdaq Biotechnology -2x Shares Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 65.95 K | $582.31 K | 129.36% | 23.06% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 2.65 K | $23.39 K | 148.97% | 0.93% |
| MORGAN STANLEY | 05/15/2026 | 2 | $21 | 100.00% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 1 | $9 | 0.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ProShares UltraShort Nasdaq Biotechnology -2x Shares institutional Ownership - FAQ's
During the previous two years, 4 institutional investors and hedge funds held shares of ProShares UltraShort Nasdaq Biotechnology -2x Shares. The most heavily invested institutionals were:
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 65,947
Tower Research Capital LLC (TRC): 2,649
MORGAN STANLEY: 2
UBS Group AG: 1
23.99% of ProShares UltraShort Nasdaq Biotechnology -2x Shares stock is owned by institutional investors.
Institutional investors have bought a total of 68.60 K shares in the last 24 months. This purchase volume represents approximately $602.30 K in transactions.